HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akiko Mammoto Selected Research

ARG tyrosine kinase

10/2008ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akiko Mammoto Research Topics

Disease

17Neoplasms (Cancer)
09/2017 - 09/2002
5Breast Neoplasms (Breast Cancer)
07/2017 - 10/2010
4Neoplasm Metastasis (Metastasis)
01/2013 - 09/2002
3Sepsis (Septicemia)
01/2015 - 01/2013
3Inflammation (Inflammations)
08/2013 - 08/2007
2Atherosclerosis
01/2021 - 01/2016
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 11/2016
2Hypoxia (Hypoxemia)
01/2020 - 01/2018
2Circulating Neoplastic Cells
07/2017 - 06/2012
2Pathologic Neovascularization
11/2016 - 10/2011
2Lung Diseases (Lung Disease)
01/2015 - 12/2014
2Pulmonary Edema
01/2015 - 01/2013
2Glioblastoma (Glioblastoma Multiforme)
10/2013 - 01/2013
2Brain Neoplasms (Brain Tumor)
10/2013 - 01/2013
2Osteosarcoma (Osteogenic Sarcoma)
10/2002 - 09/2002
1Familial Primary Pulmonary Hypertension
01/2020
1Pulmonary Arterial Hypertension
01/2018
1Pulmonary Hypertension
01/2018
1Albuminuria
01/2017
1Kidney Diseases (Kidney Disease)
01/2017
1Skin Neoplasms (Skin Cancer)
07/2015
1Sarcoma (Soft Tissue Sarcoma)
12/2014
1Choroidal Neovascularization
11/2014
1Medulloblastoma
07/2014
1Hematologic Diseases (Blood Diseases)
06/2014
1Arteriovenous Malformations (Arteriovenous Malformation)
06/2014
1Vascular Malformations
06/2014
1Corneal Neovascularization
08/2013
1Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2013
1Lung Injury
01/2013
1Bronchopulmonary Dysplasia
01/2013
1Carcinogenesis
01/2012
1Metrorrhagia (Spotting)
05/2011

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015 - 08/2008
6Proteins (Proteins, Gene)FDA Link
07/2015 - 07/2007
5Transcription Factors (Transcription Factor)IBA
01/2021 - 11/2014
4Pharmaceutical PreparationsIBA
09/2017 - 06/2012
4EnzymesIBA
10/2013 - 01/2012
3CollagenIBA
11/2016 - 10/2013
2HydrogelsIBA
01/2020 - 12/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2017 - 01/2017
2Epithelial Cell Adhesion MoleculeIBA
07/2017 - 06/2012
2Twist-Related Protein 1IBA
01/2016 - 11/2014
2EndotoxinsIBA
01/2015 - 01/2013
2matrigelIBA
12/2014 - 01/2013
2GelsIBA
12/2014 - 08/2008
2Netrin-1IBA
07/2014 - 01/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2014 - 09/2002
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
10/2013 - 06/2012
2LipidsIBA
08/2013 - 01/2012
2Small Interfering RNA (siRNA)IBA
08/2013 - 08/2007
2Oxygen (Dioxygen)IBA
01/2013 - 10/2011
2Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
11/2003 - 09/2002
2Anesthetics (Anesthetic Agents)IBA
10/2002 - 09/2002
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
01/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
07/2017
1AntibodiesIBA
07/2017
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
07/2017
1BuffersIBA
07/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2016
1TIE-2 Receptor (Receptor, TIE 2)IBA
01/2015
1FibrinIBA
12/2014
1Biocompatible Materials (Biomaterials)IBA
12/2014
1Messenger RNA (mRNA)IBA
07/2014
1neogeninIBA
07/2014
1Biomarkers (Surrogate Marker)IBA
07/2014
1Mechanistic Target of Rapamycin Complex 1IBA
06/2014
1p120 GTPase Activating ProteinIBA
06/2014
1Neuropilin-2IBA
04/2014
1PaxillinIBA
04/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2013
1AminopropionitrileIBA
10/2013
1CopperIBA
10/2013
1Penicillamine (Cuprimine)FDA Link
10/2013
1AcidsIBA
08/2013
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2013
1Retinaldehyde (Retinal)IBA
08/2013
1TenascinIBA
08/2013
1Estrogen ReceptorsIBA
08/2013
1BiglycanIBA
08/2013
1Annexin A2 (Annexin II)IBA
01/2013
1Cathepsin BIBA
01/2013
1Cysteine Proteases (Cysteine Protease)IBA
01/2013
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
01/2013
1Tumor Viral Antigens (Large T Antigen)IBA
06/2012
1DAPIIBA
06/2012
1baysilon (polydimethylsiloxane)IBA
06/2012
1Keratins (Keratin)IBA
06/2012
1Fluorescein-5-isothiocyanate (FITC)IBA
06/2012
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
06/2012
1Epoxide HydrolasesIBA
01/2012
1Wnt ReceptorsIBA
10/2011
1LDL Receptors (LDL Receptor)IBA
10/2011
1CelluloseIBA
05/2011
1FilaminsIBA
10/2010

Therapy/Procedure

4Therapeutics
10/2014 - 10/2011
2Artificial Respiration (Mechanical Ventilation)
01/2015 - 01/2013
1Lasers (Laser)
11/2014
1Lab-On-A-Chip Devices
06/2012